Guidance: List the most important benefits and risks. Weights should reflect relative importance (sum to 100% within each category). Scores represent magnitude (0-10 scale).
KCBs
max 8
Benefits: Weight = importance relative to other benefits (%), Score = magnitude of benefit (0-10)
Benefit
Weight %
Score 0–10
Weights sum:
0%
KSRs
max 8
Risks: Weight = importance relative to other risks (%), Severity = seriousness of risk (0-10)
Risk
Weight %
Severity 0–10
Weights sum:
0%
Weighted benefit
0.00
Weighted risk
0.00
Net (Benefit − Risk)
0.00
Warnings
—
3) Number Needed Analyses (NNT / NNH)
Guidance: Calculate NNT (Number Needed to Treat) for benefits and NNH (Number Needed to Harm) for risks. Use event rates from clinical trials.
NNT/NNH Interpretation
Click "Interpret Results" to see analysis
Benefit Event
Enter event rates for the primary benefit endpoint
ARR: — • NNT: —
Harm Event
Enter event rates for the primary safety concern
ARI: — • NNH: —
Helped vs Harmed (LHH = NNH/NNT)
LHH > 1.5 suggests more helped than harmed
—
Like-for-like severity
Are benefit and risk events comparable in clinical importance?
4) WVT / MCDA Summary
Guidance: Review and adjust weights/scores, test sensitivity with sliders, and create custom scenarios to explore different assumptions.
MCDA Interpretation
Click "Interpret Results" to see analysis
Computation Mode
Normalize: weights sum to 100% within benefits and risks separately
Base Case
Current weighted benefit-risk calculation
Benefit: 0.00
Risk: 0.00
Net: 0.00
Interactive Emphasis
Test how changing emphasis affects the net benefit-risk balance
Benefit emphasis
100%
Risk emphasis
100%
Interactive Net: 0.00
Quick Edit — KCB
Directly edit benefits here - changes reflect in main table
Benefit
Weight %
Score
Quick Edit — KSR
Directly edit risks here - changes reflect in main table
Risk
Weight %
Severity
Custom Sensitivity Scenarios
Test different assumptions by creating scenarios with varying benefit/risk emphasis
Scenario Label
Benefit Mult %
Risk Mult %
Net
5) Effects Table (Snapshot)
Guidance: Document key efficacy and safety results. Include both favorable and unfavorable findings to support the overall assessment.
Effects Table Interpretation
Click "Interpret Results" to see analysis
Effect / Endpoint
Drug
Control
Comment
6) Decision Builder
Guidance: Synthesize all information into a comprehensive decision. Address risks and uncertainties with specific plans.
Specific actions to manage identified risks (e.g., monitoring, contraindications, dose adjustments)
How will remaining uncertainties be addressed? (e.g., additional studies, post-marketing surveillance)
Overall benefit-risk conclusion based on the analysis
Key considerations or rationale for the recommendation
Auto signals
Decision (computed)
—
7) Export Report
Guidance: Generate a comprehensive report summarizing the entire benefit-risk assessment. Use for documentation, regulatory submissions, or team discussions.